SBIA
SPPI

Sheaff Brock Investment Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,200
Closed -$36.7K – 502
2023
Q2 		$36.7K Sell
38,200
-9,000
-19% -$8.89K ﹤0.01% 482
2023
Q1 		$35.4K Buy
47,200
+2,000
+4% +$1.46K ﹤0.01% 506
2022
Q4 		$16.7K Buy
45,200
+8,000
+22% +$3.37K ﹤0.01% 503
2022
Q3 		$16K Buy
37,200
+11,000
+42% +$10.8K ﹤0.01% 491
2022
Q2 		$20K Buy
26,200
+3,000
+13% +$2.64K ﹤0.01% 496
2022
Q1 		$30K Buy
23,200
+6,000
+35% +$5.53K ﹤0.01% 533
2021
Q4 		$22K Buy
17,200
+4,600
+37% +$8.22K ﹤0.01% 542
2021
Q3 		$27K Buy
+12,600
New +$34.4K ﹤0.01% 548

Sheaff Brock Investment Advisors's SPPI Position: Q3 2023 in Review

Sheaff Brock Investment Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 38,200 shares — an estimated $36.7K sold.

Sheaff Brock Investment Advisors first reported a position in SPPI in Q3 2021 and held it in 8 quarters. The position peaked at $36.7K in Q2 2023. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Sheaff Brock Investment Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 38,200 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $36.7K.
  • Sheaff Brock Investment Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q3 2021 and held it in 8 quarters.
  • Sheaff Brock Investment Advisors's Spectrum Pharmaceuticals Inc position peaked at $36.7K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Sheaff Brock Investment Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.